In light of the large number of studies published since the 2004 update of Schizophrenia
Patient Outcomes Research Team psychopharmacological treatment recommendations, we …

OBJECTIVE: Schizophrenia is associated with several chronic physical illnesses and a shorter
life expectancy, compared with life expectancy in the general population. One approach …

The Schedule for the Deficit Syndrome (SDS) is an instrument for categorizing schizophrenic
patients into those with and those without the deficit syndrome. In a study of 40 …

Objective: Research and clinical translation in schizophrenia is limited by inconsistent
definitions of treatment resistance and response. To address this issue, the authors evaluated …

If schizophrenia is a clinical syndrome rather than a single disease, the identification of
specific diseases within the syndrome would facilitate the advance of knowledge and the …

Since publication of the original Schizophrenia Patient Outcomes Research Team (PORT)
treatment recommendations in 1998, considerable scientific advances have occurred in our …

… In reviewing this literature (Heinrichs and Buchanan, 1988), … risk before the onset of their
illness (Heinrichs and Buchanan, … exact methods are not described (Heinrichs and Buchanan, …

• We used magnetic resonance imaging to examine the morphologic characteristics of the
amygdala/hippocampus, prefrontal cortex, and caudate nucleus in 29 healthy volunteers …

The Schizophrenia Patient Outcomes Research Team (PORT) project has played a significant
role in the development and dissemination of evidence-based practices for schizophrenia. …

Objective: On April 23, 2004, a joint meeting of the FDA, NIMH, MATRICS investigators, and
experts from academia and the pharmaceutical industry was convened to develop …